SUMO-1 modification increases human SOD1 stability and aggregation

被引:83
作者
Fei, Erkang
Jia, Nali
Yan, Ming
Ying, Zheng
Sun, Qiang
Wang, Hongfeng
Zhang, Tao
Ma, Xiaochuan
Ding, Husheng
Yao, Xuebiao
Shi, Yunyu
Wang, Guanghui [1 ]
机构
[1] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China
[2] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China
关键词
familial amyotrophic lateral sclerosis (FALS); copper-zinc superoxide dismutase (SOD1); sumoylation;
D O I
10.1016/j.bbrc.2006.06.092
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mutations in the gene encoding copper-zinc superoxide dismutase (SOD1) cause approximately 20% cases of familial amyotrophic lateral sclerosis (FALS), characterized by selective loss of motor neurons. Mutant SOD1 forms inclusions in tissues from FALS patients. However, the precise mechanism of the accumulation of mutant SOD1 remains unclear. Here we show that human SOD1 is a substrate modified by SUMO-1. A conversion of lysine 75 to an arginine within a SUMO consensus sequence in SOD1 completely abolishes SOD1 sumoylation. We further show that SUMO-I modification, on both wild-type and mutant SOD1, increases SOD1 steady state level and aggregation. Moreover, SUMO-1 co-localizes onto the aggregates formed by SOD1. These findings imply that SUMO-1 modification on lysine 75 may participate in regulating SOD I stability and its aggregation process. Thus, our results suggest that sumoylation of SOD1 may be involved in the pathogenesis of FALS associated with mutant SOD1. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 41 条
[1]   Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene [J].
Andersen, Peter M. .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (01) :37-46
[2]   Structure determination of the small ubiquitin-related modifier SUMO-1 [J].
Bayer, P ;
Arndt, A ;
Metzger, S ;
Mahajan, R ;
Melchior, F ;
Jaenicke, R ;
Becker, J .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (02) :275-286
[3]   A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus [J].
Bohren, KM ;
Nadkarni, V ;
Song, JH ;
Gabbay, KH ;
Owerbach, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :27233-27238
[4]   Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1 [J].
Bruijn, LI ;
Houseweart, MK ;
Kato, S ;
Anderson, KL ;
Anderson, SD ;
Ohama, E ;
Reaume, AG ;
Scott, RW ;
Cleveland, DW .
SCIENCE, 1998, 281 (5384) :1851-1854
[5]   RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article) [J].
Buschmann, T ;
Fuchs, SY ;
Lee, CG ;
Pan, ZQ ;
Ronai, Z .
CELL, 2000, 101 (07) :753-762
[6]   Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome [J].
Cheroni, C ;
Peviani, M ;
Cascio, P ;
DeBlasi, S ;
Monti, C ;
Bendotti, C .
NEUROBIOLOGY OF DISEASE, 2005, 18 (03) :509-522
[7]   From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS [J].
Cleveland, DW .
NEURON, 1999, 24 (03) :515-520
[8]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[9]   SUMO-1 modification alters ADAR1 editing activity [J].
Desterro, JMP ;
Keegan, LP ;
Jaffray, E ;
Hay, RT ;
O'Connell, MA ;
Carmo-Fonseca, M .
MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (11) :5115-5126
[10]   Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and α-synuclein [J].
Dorval, V ;
Fraser, PE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :9919-9924